Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional)

US Dept. of Health & Human Services: National Institutes of Health (NIH)

Note: This grant page has been archived and is very likely out of date.

Deadline: The deadline for this grant has passed

Grant amount: Up to US $500,000

Fields of work: Drug Abuse

Applicant type: Government Entity, Nonprofit, For-Profit Business, Indigenous Group

Funding uses: Biomedical

Location of project: Anywhere in the world

Location of residency: Anywhere in the world



Letter of intent: Although a letter of intent is not required, is not binding, and does not enter into the review of a subsequent application, the information that it contains allows IC staff to estimate the potential review workload and plan the review. prospective applicants are asked to submit a letter of intent 30 days prior to the application due date.

Application dates:

  • All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates by 5 pm local time of applicant organization. 
    • October 10, 2019; July 10, 2020; March 10, 2021; October 13, 2021; July 11, 2022; March 10, 2023, by 5:00 PM
  • All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on these dates by 5 pm local time of applicant organization
    • January 7, 2020; September 7, 2020; May 7, 2021; January 7, 2022; September 7, 2022; May 7, 2023 by 5:00 PM local time of applicant organization. 

This Funding Opportunity Announcement (FOA) uses a R61/R33 Phased Innovation Award mechanism to support clinical research applications that are exploratory and developmental in nature and focus on understanding the neurobiological mechanisms underlying SUD, including fundamental brain function relevant to substance use. This FOA is particularly designed to support exploratory/developmental projects requiring budgets that would exceed that allowed for the R21 mechanism (Neuroscience Research on Drug Abuse (R21 Clinical Trial Optional)

We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website.

Other Opportunities from Us Dept. Of Health & Human Services: National Institutes Of Health (Nih)

This page was last reviewed October 07, 2022 and last updated May 16, 2019